We have previously shown that participation of surface HSP90 in cancer cell invasion processes occurs through its interaction with the extracellular domain of HER-2 in MDA-MB-453 cells, and that this interaction is disrupted by a the cell impermeable anti-HSP90 antibody mAb 4C5 [28]. The gene discussed is ERBB2; the disease is cancer.